Deals17 Feb 2026, 01:37 pm
Dr Agarwals Eye Hospital Ltd Receives 'No Adverse Observations' from BSE for Scheme of Amalgamation
AI Summary
Dr Agarwals Eye Hospital Ltd has received an observation letter from BSE Limited conveying 'no adverse observations' in relation to the Scheme of Amalgamation of Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited. The Scheme is subject to the receipt of necessary statutory and regulatory approvals, including the approvals of the respective shareholders and creditors of the companies involved in the Scheme, and the jurisdictional National Company Law Tribunal.
Key Highlights
- Dr Agarwals Eye Hospital Ltd has received 'no adverse observations' from BSE Limited for the Scheme of Amalgamation with Dr. Agarwal’s Health Care Limited.
- The Scheme is subject to the receipt of necessary statutory and regulatory approvals.
- The approval from BSE Limited is a significant step towards the completion of the Scheme.
- The Scheme aims to amalgamate Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited.
- The companies involved in the Scheme are awaiting necessary approvals from various regulatory bodies.
Price Impact
More from DRAGARWQ